Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

King of Prussia, Pennsylvania


This study is being carried out to see if budesonide with HFA is effective, safe and well tolerated compared with budesonide CFC. Budesonide HFA has been already given in other research studies, in both healthy volunteers and subjects with asthma.


Inclusion Criteria: - Patients suffering from stable, persistent, mild to moderate asthma as defined by Global Initiative for Asthma (GINA) Guidelines and for whom FEV1 > 60 % - ICS taking ≤ 1000 μg BDP per day, or equivalent - Methacholine PC20 < 4 mg/mL Exclusion Criteria: - Known or suspected hypersensitivity to budesonide or any other constituents of the budesonide HFA pMDI or budesonide CFC pMDI. - Currently a smoker or who has ceased smoking within 6 months of Visit 1. - Exacerbations of asthma requiring oral steroids, hospitalisation or change in asthma therapy in the previous three months. - Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or bronchiectasis



Primary Contact:

Principal Investigator
Brian Lipworth, PhD, MD
Asthma and Allergy Research Group Division of Medicine and Therapeutics Ninewells Hospital and Medic

Backup Contact:


Location Contact:

King of Prussia, Pennsylvania
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.